MedPath

FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Vitamin D Supplementation for the Prevention of Cardiovascular Risk

Phase 4
Completed
Conditions
Obesity
Overweight
Insulin Resistance
Interventions
Drug: Vitamin D
Drug: Placebo (for vitamin D)
First Posted Date
2013-12-25
Last Posted Date
2023-04-19
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
60
Registration Number
NCT02020694
Locations
🇮🇹

Catholic University of Sacred Heart, Rome, Italy

© Copyright 2025. All Rights Reserved by MedPath